Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s00125-006-0338-9.

Title:
Metformin influences cardiomyocyte cell death by pathways that are dependent and independent of caspase-3 | Diabetologia
Description:
Aims/hypothesis Metformin has been shown to increase fatty acid oxidation, an effect mediated by AMP activated protein kinase (AMPK). We hypothesised that metformin could prevent both caspase-3 activation and apoptosis when induced by palmitic acid. Materials and methods Cardiomyocytes were incubated with 1 mmol/l palmitic acid, in the absence or presence of metformin (1–5 mmol/l). Following 1 to 16 h, cell damage was evaluated by measuring lactate dehydrogenase released into the incubation medium, and Hoechst staining. To investigate the mechanism of metformin’s effect on cardiomyocytes, substrate utilisation and phosphorylation of AMPK and acetyl-CoA carboxylase were measured. Intracellular mediators of apoptosis were also evaluated. Results Incubation of myocytes with palmitic acid for 16 h increased apoptosis, an effect that was partly blunted by 1 and 2 mmol/l metformin. This beneficial effect of metformin was associated with increased AMPK phosphorylation, palmitic acid oxidation and suppression of high-fat-induced increases in (1) long chain base biosynthesis protein 1 levels, (2) ceramide levels, and (3) caspase-3 activity. Unexpectedly, 5 mmol/l metformin dramatically increased apoptosis in myocytes incubated with high fat. This effect was associated with a robust increase in glycolysis, lactate accumulation, and a significant drop of pH in the myocyte incubation medium. Conclusions/interpretation Our study demonstrates that metformin reduces high-fat-induced cardiac cell death, probably through inhibition of ceramide synthesis. However, at high concentrations, metformin causes proton and lactate accumulation, leading to cell damage that is independent of caspase-3.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Health & Fitness
  • Education
  • Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We're unsure how the site profits.

Not all websites focus on profit; some are designed to educate, connect people, or share useful tools. People create websites for numerous reasons. And this could be one such example. Link.springer.com could be secretly minting cash, but we can't detect the process.

Keywords {🔍}

metformin, acid, mmoll, article, pubmed, google, scholar, cas, apoptosis, cell, fatty, protein, ceramide, oxidation, ampk, fig, palmitic, activation, cardiomyocytes, diabetes, glucose, caspase, incubation, death, medium, control, high, cells, glycolysis, ldh, kinase, lactate, increased, release, incubated, difference, ros, effect, data, myocytes, highfatinduced, cardiomyocyte, phosphorylation, activity, heart, measured, levels, fat, usa, absence,

Topics {✒️}

high-fat-induced cell death amp-activated protein kinase study high-fat-induced apoptosis hickson-bick dl secondary goat anti-rabbit palmitate-induced cardiomyocyte apoptosis high-fat-induced increases high-fat-induced apoptotic cells high-fat-induced lcb-1 reactive oxygen species nitric oxide-induced apoptosis fluorescent dna-binding dye fatty acid-induced apoptosis 5% octyl-β-d-glucoside high-fat-induced activation exercise-induced metabolic acidosis sds-polyacrylamide gel electrophoresis exogenous c2-ceramide mimics albumin-bound palmitic acid glucose fatty-acid cycle magnesium-dependent neutral sphingomyelinase high-fat-treated group hyperglycemia-induced apoptosis cell death induced palmitate-induced apoptosis preventing cell death long lcb1 antibodies 32p-labelled ceramide 1-phosphate mitochondrial redox state malonyl-coa levels due nitric oxide signaling caspase-3 article published stimulates glucose uptake prevent cell death promotes mitochondrial biogenesis graduate research scholarships increased lcb1 protein privacy choices/manage cookies cardiac lcb1 expression cyclophosphamide-induced cardiotoxicity fatty acids accumulate altered glucose transport rat cardiac camp calcium-tolerant myocardial cells palmitate-mediated alterations promotes fatty acid fatty acid oxidation increasing mitochondrial cytochrome fatty acid spillover carnitine palmitoyl transferase-1

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Metformin influences cardiomyocyte cell death by pathways that are dependent and independent of caspase-3
         description:Metformin has been shown to increase fatty acid oxidation, an effect mediated by AMP activated protein kinase (AMPK). We hypothesised that metformin could prevent both caspase-3 activation and apoptosis when induced by palmitic acid. Cardiomyocytes were incubated with 1 mmol/l palmitic acid, in the absence or presence of metformin (1–5 mmol/l). Following 1 to 16 h, cell damage was evaluated by measuring lactate dehydrogenase released into the incubation medium, and Hoechst staining. To investigate the mechanism of metformin’s effect on cardiomyocytes, substrate utilisation and phosphorylation of AMPK and acetyl-CoA carboxylase were measured. Intracellular mediators of apoptosis were also evaluated. Incubation of myocytes with palmitic acid for 16 h increased apoptosis, an effect that was partly blunted by 1 and 2 mmol/l metformin. This beneficial effect of metformin was associated with increased AMPK phosphorylation, palmitic acid oxidation and suppression of high-fat-induced increases in (1) long chain base biosynthesis protein 1 levels, (2) ceramide levels, and (3) caspase-3 activity. Unexpectedly, 5 mmol/l metformin dramatically increased apoptosis in myocytes incubated with high fat. This effect was associated with a robust increase in glycolysis, lactate accumulation, and a significant drop of pH in the myocyte incubation medium. Our study demonstrates that metformin reduces high-fat-induced cardiac cell death, probably through inhibition of ceramide synthesis. However, at high concentrations, metformin causes proton and lactate accumulation, leading to cell damage that is independent of caspase-3.
         datePublished:2006-07-26T00:00:00Z
         dateModified:2006-07-26T00:00:00Z
         pageStart:2174
         pageEnd:2184
         sameAs:https://doi.org/10.1007/s00125-006-0338-9
         keywords:
            AMPK
            Apoptosis
            Cardiomyocyte
            Metformin
            Palmitic acid
            Internal Medicine
            Metabolic Diseases
            Human Physiology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00125-006-0338-9/MediaObjects/125_2006_338_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00125-006-0338-9/MediaObjects/125_2006_338_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00125-006-0338-9/MediaObjects/125_2006_338_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00125-006-0338-9/MediaObjects/125_2006_338_Fig4_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00125-006-0338-9/MediaObjects/125_2006_338_Fig5_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00125-006-0338-9/MediaObjects/125_2006_338_Fig6_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00125-006-0338-9/MediaObjects/125_2006_338_Fig7_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00125-006-0338-9/MediaObjects/125_2006_338_Fig8_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00125-006-0338-9/MediaObjects/125_2006_338_Fig9_HTML.gif
         isPartOf:
            name:Diabetologia
            issn:
               1432-0428
               0012-186X
            volumeNumber:49
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer-Verlag
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:D. An
               affiliation:
                     name:The University of British Columbia
                     address:
                        name:Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, Canada
                        type:PostalAddress
                     type:Organization
               type:Person
               name:G. Kewalramani
               affiliation:
                     name:The University of British Columbia
                     address:
                        name:Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, Canada
                        type:PostalAddress
                     type:Organization
               type:Person
               name:J. K. Y. Chan
               affiliation:
                     name:The University of British Columbia
                     address:
                        name:Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, Canada
                        type:PostalAddress
                     type:Organization
               type:Person
               name:D. Qi
               affiliation:
                     name:The University of British Columbia
                     address:
                        name:Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, Canada
                        type:PostalAddress
                     type:Organization
               type:Person
               name:S. Ghosh
               affiliation:
                     name:The University of British Columbia
                     address:
                        name:Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, Canada
                        type:PostalAddress
                     type:Organization
               type:Person
               name:T. Pulinilkunnil
               affiliation:
                     name:The University of British Columbia
                     address:
                        name:Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, Canada
                        type:PostalAddress
                     type:Organization
               type:Person
               name:A. Abrahani
               affiliation:
                     name:The University of British Columbia
                     address:
                        name:Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, Canada
                        type:PostalAddress
                     type:Organization
               type:Person
               name:S. M. Innis
               affiliation:
                     name:The University of British Columbia
                     address:
                        name:Department of Pediatrics, The University of British Columbia, Vancouver, Canada
                        type:PostalAddress
                     type:Organization
               type:Person
               name:B. Rodrigues
               affiliation:
                     name:The University of British Columbia
                     address:
                        name:Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, Canada
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Metformin influences cardiomyocyte cell death by pathways that are dependent and independent of caspase-3
      description:Metformin has been shown to increase fatty acid oxidation, an effect mediated by AMP activated protein kinase (AMPK). We hypothesised that metformin could prevent both caspase-3 activation and apoptosis when induced by palmitic acid. Cardiomyocytes were incubated with 1 mmol/l palmitic acid, in the absence or presence of metformin (1–5 mmol/l). Following 1 to 16 h, cell damage was evaluated by measuring lactate dehydrogenase released into the incubation medium, and Hoechst staining. To investigate the mechanism of metformin’s effect on cardiomyocytes, substrate utilisation and phosphorylation of AMPK and acetyl-CoA carboxylase were measured. Intracellular mediators of apoptosis were also evaluated. Incubation of myocytes with palmitic acid for 16 h increased apoptosis, an effect that was partly blunted by 1 and 2 mmol/l metformin. This beneficial effect of metformin was associated with increased AMPK phosphorylation, palmitic acid oxidation and suppression of high-fat-induced increases in (1) long chain base biosynthesis protein 1 levels, (2) ceramide levels, and (3) caspase-3 activity. Unexpectedly, 5 mmol/l metformin dramatically increased apoptosis in myocytes incubated with high fat. This effect was associated with a robust increase in glycolysis, lactate accumulation, and a significant drop of pH in the myocyte incubation medium. Our study demonstrates that metformin reduces high-fat-induced cardiac cell death, probably through inhibition of ceramide synthesis. However, at high concentrations, metformin causes proton and lactate accumulation, leading to cell damage that is independent of caspase-3.
      datePublished:2006-07-26T00:00:00Z
      dateModified:2006-07-26T00:00:00Z
      pageStart:2174
      pageEnd:2184
      sameAs:https://doi.org/10.1007/s00125-006-0338-9
      keywords:
         AMPK
         Apoptosis
         Cardiomyocyte
         Metformin
         Palmitic acid
         Internal Medicine
         Metabolic Diseases
         Human Physiology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00125-006-0338-9/MediaObjects/125_2006_338_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00125-006-0338-9/MediaObjects/125_2006_338_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00125-006-0338-9/MediaObjects/125_2006_338_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00125-006-0338-9/MediaObjects/125_2006_338_Fig4_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00125-006-0338-9/MediaObjects/125_2006_338_Fig5_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00125-006-0338-9/MediaObjects/125_2006_338_Fig6_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00125-006-0338-9/MediaObjects/125_2006_338_Fig7_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00125-006-0338-9/MediaObjects/125_2006_338_Fig8_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00125-006-0338-9/MediaObjects/125_2006_338_Fig9_HTML.gif
      isPartOf:
         name:Diabetologia
         issn:
            1432-0428
            0012-186X
         volumeNumber:49
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer-Verlag
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:D. An
            affiliation:
                  name:The University of British Columbia
                  address:
                     name:Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, Canada
                     type:PostalAddress
                  type:Organization
            type:Person
            name:G. Kewalramani
            affiliation:
                  name:The University of British Columbia
                  address:
                     name:Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, Canada
                     type:PostalAddress
                  type:Organization
            type:Person
            name:J. K. Y. Chan
            affiliation:
                  name:The University of British Columbia
                  address:
                     name:Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, Canada
                     type:PostalAddress
                  type:Organization
            type:Person
            name:D. Qi
            affiliation:
                  name:The University of British Columbia
                  address:
                     name:Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, Canada
                     type:PostalAddress
                  type:Organization
            type:Person
            name:S. Ghosh
            affiliation:
                  name:The University of British Columbia
                  address:
                     name:Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, Canada
                     type:PostalAddress
                  type:Organization
            type:Person
            name:T. Pulinilkunnil
            affiliation:
                  name:The University of British Columbia
                  address:
                     name:Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, Canada
                     type:PostalAddress
                  type:Organization
            type:Person
            name:A. Abrahani
            affiliation:
                  name:The University of British Columbia
                  address:
                     name:Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, Canada
                     type:PostalAddress
                  type:Organization
            type:Person
            name:S. M. Innis
            affiliation:
                  name:The University of British Columbia
                  address:
                     name:Department of Pediatrics, The University of British Columbia, Vancouver, Canada
                     type:PostalAddress
                  type:Organization
            type:Person
            name:B. Rodrigues
            affiliation:
                  name:The University of British Columbia
                  address:
                     name:Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, Canada
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Diabetologia
      issn:
         1432-0428
         0012-186X
      volumeNumber:49
Organization:
      name:Springer-Verlag
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:The University of British Columbia
      address:
         name:Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, Canada
         type:PostalAddress
      name:The University of British Columbia
      address:
         name:Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, Canada
         type:PostalAddress
      name:The University of British Columbia
      address:
         name:Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, Canada
         type:PostalAddress
      name:The University of British Columbia
      address:
         name:Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, Canada
         type:PostalAddress
      name:The University of British Columbia
      address:
         name:Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, Canada
         type:PostalAddress
      name:The University of British Columbia
      address:
         name:Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, Canada
         type:PostalAddress
      name:The University of British Columbia
      address:
         name:Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, Canada
         type:PostalAddress
      name:The University of British Columbia
      address:
         name:Department of Pediatrics, The University of British Columbia, Vancouver, Canada
         type:PostalAddress
      name:The University of British Columbia
      address:
         name:Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, Canada
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:D. An
      affiliation:
            name:The University of British Columbia
            address:
               name:Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, Canada
               type:PostalAddress
            type:Organization
      name:G. Kewalramani
      affiliation:
            name:The University of British Columbia
            address:
               name:Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, Canada
               type:PostalAddress
            type:Organization
      name:J. K. Y. Chan
      affiliation:
            name:The University of British Columbia
            address:
               name:Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, Canada
               type:PostalAddress
            type:Organization
      name:D. Qi
      affiliation:
            name:The University of British Columbia
            address:
               name:Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, Canada
               type:PostalAddress
            type:Organization
      name:S. Ghosh
      affiliation:
            name:The University of British Columbia
            address:
               name:Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, Canada
               type:PostalAddress
            type:Organization
      name:T. Pulinilkunnil
      affiliation:
            name:The University of British Columbia
            address:
               name:Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, Canada
               type:PostalAddress
            type:Organization
      name:A. Abrahani
      affiliation:
            name:The University of British Columbia
            address:
               name:Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, Canada
               type:PostalAddress
            type:Organization
      name:S. M. Innis
      affiliation:
            name:The University of British Columbia
            address:
               name:Department of Pediatrics, The University of British Columbia, Vancouver, Canada
               type:PostalAddress
            type:Organization
      name:B. Rodrigues
      affiliation:
            name:The University of British Columbia
            address:
               name:Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, Canada
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, Canada
      name:Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, Canada
      name:Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, Canada
      name:Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, Canada
      name:Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, Canada
      name:Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, Canada
      name:Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, Canada
      name:Department of Pediatrics, The University of British Columbia, Vancouver, Canada
      name:Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, Canada

External Links {🔗}(177)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

4.21s.